-
Revozyn RTU 400 mg/ml Suspension for Injection for Cattle, Recall, One batch
Mar 26, 2025, 12:43 -
Drug Safety Newsletter – Edition 118 – 25 March 2025
Mar 25, 2025, 14:59 -
PRAC meeting highlights 10-13 March 2025
Mar 14, 2025, 13:44 -
Update to Zovirax IV dosing regimen
Mar 12, 2025, 09:30 -
Summary of Field Safety Notices February 2025
Mar 11, 2025, 16:23 -
Neupogen® 30 MU (0.3 mg/ml) Solution for injection filgrastim, PA 1026/001/001, Batch Recall
Mar 6, 2025, 15:23 -
Drug Safety Newsletter – Edition 116 – 24 September 2024
Feb 28, 2025, 16:28 -
Risperidone (Risperdal®, Rispone®) 1 mg/ml Oral Solution: Risk of medication errors leading to accidental overdoses in children and adolescents
Feb 28, 2025, 12:04 -
Kexxtone 32.4g continuous-release intraruminal device for cattle, EU/2/12/145/001-003
Feb 27, 2025, 16:58 -
Summary of Field Safety Notices January 2024
Feb 18, 2025, 17:48 -
Summary of Field Safety Notices February 2024
Feb 18, 2025, 17:46 -
Summary of Field Safety Notices March 2024
Feb 18, 2025, 17:41 -
Summary of Field Safety Notices June 2024
Feb 18, 2025, 17:33 -
Summary of Field Safety Notices July 2024
Feb 18, 2025, 17:27 -
Summary of Field Safety Notices August 2024
Feb 18, 2025, 17:19 -
Atomoxetine Capsules USP 80mg, Exempt Medicinal Product (Glenmark Pharmaceuticals Inc. livery)
Feb 14, 2025, 16:37 -
PRAC meeting highlights 10-13 February 2025
Feb 14, 2025, 00:00 -
Summary of Field Safety Notices October 2024
Feb 12, 2025, 15:14 -
Summary of Field Safety Notices January 2025
Feb 12, 2025, 14:39 -
Summary of Field Safety Notices September 2024
Feb 12, 2025, 09:36
